Precision Fill Encapsulation

The Xcelodose® technology can provide the following benefits to your development program: 

Decrease development time: 
Clinical supplies can be provided in as little as three months in some cases    

Decreased API requirement:
Dosing neat API into capsules eliminates the need for much of preformulation, formulation, and analytical development

Route of administration:
Xcelodose® filled capsules are ideal for oral and inhaled administration

Decreased risk of stability issues:
Dosing neat API into capsules removes the potential for excipient interactions and uniformity problems

Accurate fill with weights as low as 1.0 mg:
Ideal for limited quantity of API and increased accuracy for early phase testing

Minimize API waste:
Avoids loss of drug found on most alternative equipment

Simplify analytical methods development and testing:
Eliminates overlaps and interferences due to excipients.  Removes need for blend uniformity method

Flexible capsule-filling options:
Size 00 to 4 in gelatin or HPMC capsule shells

Dedicated product contact parts:
No need for equipment cleaning verification analytical methods or testing

Enhanced QA documentation:
100% fill weights record

Software:
21CFR Part 11 compliant